Trials / Sponsors / Katy Peters
Katy Peters
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide Nausea, Vomiting, Glioma | Phase 2 | 2014-06-24 |
| Completed | Low Dose Naltrexone for Glioma Patients Malignant Glioma | Phase 2 | 2011-05-01 |
| Completed | AMG 102 and Avastin for Recurrent Malignant Glioma Glioblastoma Multiforme, Gliosarcoma | Phase 2 | 2010-08-01 |
| Completed | Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme Glioblastoma Multiforme, Gliosarcoma | Phase 2 | 2009-11-01 |
| Completed | Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas Brain Tumor, Glioblastoma | Phase 1 / Phase 2 | 2009-10-01 |
| Completed | Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma | Phase 1 | 2004-04-01 |